切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2023, Vol. 13 ›› Issue (03) : 139 -144. doi: 10.3877/cma.j.issn.2095-2015.2023.03.003

论著

LncRNA SNHG4表达与结直肠癌预后的关系
王健, 赵海剑, 孙静, 张晓雨, 陈柏羽()   
  1. 223002 江苏省,徐州医科大学附属淮安医院/淮安市第二人民医院胃肠外科
    214023 江苏省,南京医科大学附属无锡市人民医院消化内科
    223499 江苏淮安,南京医科大学康达学院附属涟水医院胃肠外科
  • 收稿日期:2023-01-10 出版日期:2023-06-01
  • 通信作者: 陈柏羽
  • 基金资助:
    国家自然科学基金(81800490); 江苏省六大人才高峰工程(WSW-220); 江苏省333高层次人才培养工程(BRA2017247)

Relationship between LncRNA SNHG4 expression and prognosis of colorectal cancer

Jian Wang, Haijian Zhao, Jing Sun, Xiaoyu Zhang, Baiyu Chen()   

  1. Department of Gastrointestinal Surgery, The Affiliated Huai′an Hospital of Xuzhou Medical University/Huai′an Second People′s Hospital, Huai′an 223002, China
    Department of Gastroenterology, Affiliated Wuxi People′s Hospital of Nanjing Medical University, Wuxi 214023, China
    Department of Gastrointestinal Surgery, Lianshui Hospital Affiliated to Kangda College, Nanjing Medical University, Huai′an 223499, China
  • Received:2023-01-10 Published:2023-06-01
  • Corresponding author: Baiyu Chen
引用本文:

王健, 赵海剑, 孙静, 张晓雨, 陈柏羽. LncRNA SNHG4表达与结直肠癌预后的关系[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(03): 139-144.

Jian Wang, Haijian Zhao, Jing Sun, Xiaoyu Zhang, Baiyu Chen. Relationship between LncRNA SNHG4 expression and prognosis of colorectal cancer[J/OL]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(03): 139-144.

目的

探讨长链非编码RNA(LncRNA)小核仁RNA宿主基因4(SNHG4)在结直肠癌患者肿瘤组织和癌旁对照组织中的相对表达水平差异和患者临床病理特征及预后之间的关系。

方法

收集2016年6月至2020年12月淮安市第二人民医院80例结直肠癌手术患者的临床病理特征及预后信息。采用实时荧光定量PCR方法,检测肿瘤组织和癌旁对照组织标本中LncRNA SNHG4的相对表达量。

结果

80例结直肠癌患者中有66例患者的癌组织中LncRNA SNHG4表达高于癌旁对照组织,高表达率为82.50%。癌组织中LncRNA SNHG4相对表达量是癌旁对照组织的3.774倍,差异有统计学意义(t=8.643,P<0.01)。根据LncRNA SNHG4相对表达量中位数值将患者分为高表达组和低表达组,每组各40例。LncRNA SNHG4表达水平与患者的肿瘤T分期、淋巴结转移状态、TNM分期、血浆癌胚抗原水平、组织分化程度高度相关。生存分析结果表明LncRNA SNHG4高表达组5年OS显著低于低表达组患者(χ2=4.876,P=0.027)。COX模型单因素变量分析显示TNM分期、肿瘤浸润层次、LncRNA SNHG4表达水平、肿瘤组织分化程度与结直肠癌患者的OS密切相关。COX多因素分析显示肿瘤TNM分期(Ⅲ/Ⅳ期vs Ⅰ/Ⅱ期)(HR=3.702,95% CI 1.096~12.502,P=0.035)是结直肠癌患者总生存期的独立影响因子。

结论

结直肠癌患者LncRNA SNHG4表达增加,并且LncRNA SNHG4与恶性病理特征有关。LncRNA SNHG4可促进结直肠癌的进展和转移,影响生存和预后,可作为监测结直肠癌进展和预后的生物学标志物。

Objective

To explore the relationships between the relative expression levels of long non-coding RNA(LncRNA)small nucleolar RNA host gene 4(SNHG4)in colorectal cancer tissues and adjacent normal tissues and the clinicopathological characteristics and prognosis of patients.

Methods

The clinicopathological characteristics and prognosis data of 80 colorectal cancerpatients in Huai′an Second People′s Hospital from June 2016 to December 2020 were collected.The relative expressions of LncRNA SNHG4 in cancer tissues and adjacent normal tissues were detected by real-time fluorescence quantitative PCR.

Results

The expressions of LncRNA SNHG4 in 66 cancer tissues were higher than those in corresponding adjacent normal tissues, with the high expression rate of 82.50%.The expression of LncRNA SNHG4 in cancer tissues was 3.774 times higher than that in corresponding adjacent normal tissues, with a statistically significant difference(t=8.643, P<0.01).The patients were divided into high expression group and low expression group according to the median of the relative expression of LncRNA SNHG4, with 40 cases in each group.The expression level of LncRNA SNHG4 was highly correlated with the tumor T stage, lymph node metastasis status, TNM stage, plasma carcinoembryonic antigenlevel, and the degree of tissue differentiation of the patients.Survival analysis showed that the 5-year OS rate of the LncRNA high expression group was significantly lower than that of the low expression group(χ2=4.876, P=0.027).COX univariate analysis showed that TNM stage, level of tumor invasion, LncRNA SNHG4 expression level, and degree of tumor tissue differentiation were related to OS of colorectal cancer patients.COX multivariate analysis showed that tumor TNM stage(stage Ⅲ/Ⅳ vs.stage Ⅰ/Ⅱ)(HR=3.702, 95% CI: 1.096~12.502, P=0.035)was an independent risk factor of OS of colorectal cancer patients.

Conclusion

The expression of LncRNA SNHG4 increases in colorectal cancer patients.LncRNA SNHG4 is related to the malignant pathological characteristics.LncRNA SNHG4 can promote the progression and metastasis of colorectal cancer, and affect the survival and prognosis.It can be used as a biological marker to monitor the progression and prognosis of colorectal cancer.

图1 LncRNA SNHG4在结直肠癌癌组织与癌旁组织表达水平比较(-△△CT)注:80例结直肠癌患者癌组织中IncRNA SNHG4表达量高于癌旁正常组织者达66例,高表达率为82.50%
图2 LncRNA SNHG4在结直肠癌癌组织和癌旁对照组织中表达量的差异倍数(将癌旁对照组织标准化值设为1)注:癌组织中LncRNA SNHG4表达是癌旁对照组织的3.774倍,差异有统计学意义(t=8.643,P<0.01)
表1 SNHG4表达与结直肠癌临床病理特征之间的关系
图3 结直肠癌患者5年总生存时间的K-M生存曲线注:IncRNA SNHG4高表达患者5年总生存率为58.8%(20/34),IncRNA SNHG4低表达组患者5年总生存率81.8%(27/33),差异有统计学意义(χ2=4.876,P=0.027)
表2 结直肠癌术后单因素及多因素Cox回归分析
1
Siegel RLMiller KDJemal A.Cancer statistics,2020[J].CA Cancer J Clin202070(1):7-30.
2
Abel YRederstorff M.SnoRNAs and the emerging class of sdRNAs:Multifaceted players in oncogenesis[J].Biochimie2019164:17-21.
3
Wang FQuan Q.The long non-coding RNA SNHG4/microRNA-let-7e/KDM3A/p21 pathway is involved in the development of non-small cell lung cancer[J].Molecular Therapy-Oncolytics202120:634-645.
4
Lan H.Regulatory Effects of LncRNA SNHG4 on miR-25/FBXW7 Axis in Papillary Thyroid Cancer Cells[J].Crit Rev Eukaryot Gene Expr202232(7):1-9.
5
Cheng XBZhang TZhu HJ,et al.Knockdown of lncRNA SNHG4 suppresses gastric cancer cell proliferation and metastasis by targeting miR-204-5p[J].Neoplasma202168(3):546-556.
6
Liu YYao HZhou B.Updates and interpretations of AJCC Cancer Staging Manual 8th edition for colorectal carcinoma[J].Chinese Journal of Practical Surgery201737(1):6-9.
7
Shi XSun MLiu H,et al.Long non-coding RNAs:A new frontier in the study of human diseases[J].Cancer Letters2013339(2):159-166.
8
Wei DMJiang MTLin P,et al.Potential ceRNA networks involved in autophagy suppression of pancreatic cancer caused by chloroquine diphosphate:A study based on differentially-expressed circRNAs,lncRNAs,miRNAs and mRNAs[J].Int J Oncol201954(2):600-626.
9
Dinger MEPang KCMercer TR,et al.Differentiating protein-coding and noncoding RNA:challenges and ambiguities[J].PLoS Comput Biol20084(11):e1000176.
10
Rinn JLChang HY.Genome Regulation by Long Noncoding RNAs[M]∥KORNBERG RD.Annual Review of Biochemistry,Vol 81.2012:145-166.
11
Nagano TFraser P.No-Nonsense Functions for Long Noncoding RNAs[J].Cell2011145(2):178-181.
12
Williams GTFarzaneh F.Are snoRNAs and snoRNA host genes new players in cancer?[J].Nature Reviews Cancer201212(2):84-88.
13
Qin YSun WWang Z,et al.Long Non-Coding Small Nucleolar RNA Host Genes(SNHGs)in Endocrine-Related Cancers[J].Onco Targets Ther202013:7699-7717.
14
Wang SZhu WQiu J,et al.lncRNA SNHG4 promotes cell proliferation,migration,invasion and the epithelial-mesenchymal transition process via sponging miR-204-5p in gastric cancer[J].Mol Med Rep202123(1):85.
15
Wu JLiu TSun L,et al.Long noncoding RNA SNHG4 promotes renal cell carcinoma tumorigenesis and invasion by acting as ceRNA to sponge miR-204-5p and upregulate RUNX2[J].Cancer Cell Int202020(1):514.
16
Wang XTian WWu L,et al.LncRNA SNHG4 regulates miR-138/c-Met axis to promote the proliferation of glioblastoma cells[J].Neuroreport202031(9):657-662.
17
Wang ZYDuan YWang P.SP1-mediated upregulation of lncRNA SNHG4 functions as a ceRNA for miR-377 to facilitate prostate cancer progression through regulation of ZIC5[J].J Cell Physiol2020235(4):3916-3927.
18
Jiao YLi YJia B,et al.The prognostic value of lncRNA SNHG4 and its potential mechanism in liver cancer[J].Biosci Rep202040(1):BSR20190729.
19
Xu RFeng FYu X,et al.LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and predicts poor survival and recurrence in human osteosarcoma[J].Cell Prolif201851(6):e12515.
[1] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[2] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[3] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[4] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[5] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[6] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[7] 陈樽, 王平, 金华, 周美玲, 李青青, 黄永刚. 肌肉减少症预测结直肠癌术后切口疝发生的应用研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 639-644.
[8] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[9] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[10] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[11] 赵泽云, 李建男, 王旻. 中性粒细胞胞外诱捕网在结直肠癌中的研究进展[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 524-528.
[12] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[13] 王湛, 李文坤, 杨奕, 徐芳, 周敏思, 苏珈仪, 王亚丹, 吴静. 炎症指标在早发性结直肠肿瘤中的应用[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 802-810.
[14] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?